ABOUT LABCONNECT
LabConnect® is a global central laboratory services and clinical trial sample solutions partner, connecting the full sample journey, from biomarker strategy and custom kitting through testing, storage, and submission-ready data. The company combines scientific and operational expertise, its global alliance of clinical and specialty laboratories, worldwide logistics oversight, and integrated data services to support routine and specialized testing across complex global studies. LabConnect helps pharmaceutical, biotechnology, and contract research organizations reduce operational risk, improve study predictability, and generate meaningful insights from each sample. Visit LabConnect.com.
VIDEOS
Central Laboratory Solutions
Global clinical trials need central laboratory networks able to scale across countries while keeping biomarker and biospecimen data consistent from one study site to the next.
CONTACT INFORMATION
LabConnect
5425 Page Rd, Suite 230
Durham, NC 27703
UNITED STATES
FEATURED INSIGHTS
-
![GettyImages-2257501711-lab-data-scientist-operations]( "Early-Phase Lab Data: Why It Breaks And How To Prevent Risk")
Learn why lab data systems built quickly in early-phase trials tend to outlast their usefulness, quietly accumulating inconsistencies that surface only when scrutiny intensifies later in a study.
-
![GettyImages-174694665 Australia flag]( "Why U.S. Sponsors Should Conduct Clinical Trials In Australia")
Faster approvals, refundable tax offsets, and a large patient population raise a pointed question: does Australia now outperform U.S. sites for early trial start-up?
-
![GettyImages-1217285194 vials, test tubes, drug development]( "Selecting A Central Lab Network For Radiopharmaceutical Readiness")
A wave of late-stage radiopharmaceutical trials is straining lab infrastructure concentrated in a handful of academic centers, limiting site diversity, expertise, and trial capacity nationwide.
-
![clinical-trials-tech-GettyImages-1867575053]( "The Future Of Clinical Trials: 7 Trends Redefining FSP Models By 2030")
Learn why factors like decentralized trials and tighter global rules are pushing sponsors to favor fewer, deeply integrated, tech-driven partners over traditional staffing models for clinical outsourcing.
-
![GettyImages-1600719545 lab]( "The Answer To Advance Your Allogeneic CAR-T Cell Clinical Trial")
Dozens of assays, a shifting sample analysis plan, and a network of specialty labs: see how coordinated oversight kept an allogeneic CAR-T trial on track.
